McKesson Corporation (0JZU.L)
USD 705.49
(-0.86%)
USD 705.49
(-0.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.9 Billion USD | -12.22% |
| 2022 | 4.45 Billion USD | 63.53% |
| 2021 | 2.72 Billion USD | -22.42% |
| 2020 | 3.51 Billion USD | 16.53% |
| 2019 | 3.01 Billion USD | -2.14% |
| 2018 | 3.07 Billion USD | 5.37% |
| 2017 | 2.92 Billion USD | -12.99% |
| 2016 | 3.35 Billion USD | -12.83% |
| 2015 | 3.85 Billion USD | 23.47% |
| 2014 | 3.11 Billion USD | 20.24% |
| 2013 | 2.59 Billion USD | 10.48% |
| 2012 | 2.34 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.02 Billion USD | -25.0% |
| 2023 Q1 | 1.03 Billion USD | -6.17% |
| 2023 Q2 | 898 Million USD | -13.15% |
| 2023 FY | 3.92 Billion USD | -11.81% |
| 2023 Q3 | 623 Million USD | -30.62% |
| 2023 Q4 | 1.37 Billion USD | 120.22% |
| 2022 Q2 | 1.14 Billion USD | 7.61% |
| 2022 Q1 | 1.06 Billion USD | 35.2% |
| 2022 Q4 | 1.1 Billion USD | -3.5% |
| 2022 FY | 4.45 Billion USD | 63.53% |
| 2022 Q3 | 1.14 Billion USD | -0.26% |
| 2021 FY | 2.72 Billion USD | -22.42% |
| 2021 Q1 | 800 Million USD | -27.8% |
| 2021 Q2 | 683 Million USD | -14.63% |
| 2021 Q4 | 787 Million USD | 143.65% |
| 2021 Q3 | 323 Million USD | -52.71% |
| 2020 Q4 | 1.1 Billion USD | 28.84% |
| 2020 FY | 3.51 Billion USD | 16.53% |
| 2020 Q1 | 596 Million USD | -34.58% |
| 2020 Q2 | 763 Million USD | 28.02% |
| 2020 Q3 | 860 Million USD | 12.71% |
| 2019 Q3 | 498 Million USD | -23.15% |
| 2019 Q4 | 911 Million USD | 82.93% |
| 2019 Q1 | 640 Million USD | -23.9% |
| 2019 Q2 | 648 Million USD | 1.25% |
| 2019 FY | 3.01 Billion USD | -2.14% |
| 2018 FY | 3.07 Billion USD | 5.37% |
| 2018 Q4 | 841 Million USD | 0.0% |
| 2018 Q3 | 841 Million USD | 4.08% |
| 2018 Q2 | 808 Million USD | 20.24% |
| 2018 Q1 | 672 Million USD | -5.75% |
| 2017 Q1 | 622 Million USD | -2.81% |
| 2017 Q2 | 831 Million USD | 33.6% |
| 2017 Q3 | 755 Million USD | -9.15% |
| 2017 Q4 | 713 Million USD | -5.56% |
| 2017 FY | 2.92 Billion USD | -12.99% |
| 2016 FY | 3.35 Billion USD | -12.83% |
| 2016 Q4 | 640 Million USD | -29.13% |
| 2016 Q3 | 903 Million USD | 0.44% |
| 2016 Q2 | 899 Million USD | -11.69% |
| 2016 Q1 | 1.01 Billion USD | 6.26% |
| 2015 FY | 3.85 Billion USD | 23.47% |
| 2015 Q4 | 958 Million USD | -1.64% |
| 2015 Q3 | 974 Million USD | -1.32% |
| 2015 Q1 | 922 Million USD | 18.81% |
| 2015 Q2 | 987 Million USD | 7.05% |
| 2014 Q4 | 776 Million USD | -5.94% |
| 2014 FY | 3.11 Billion USD | 20.24% |
| 2014 Q1 | 730 Million USD | 17.17% |
| 2014 Q2 | 817 Million USD | 11.92% |
| 2014 Q3 | 825 Million USD | 0.98% |
| 2013 FY | 2.59 Billion USD | 10.48% |
| 2013 Q1 | 683 Million USD | -5.27% |
| 2013 Q3 | 554 Million USD | -24.52% |
| 2013 Q4 | 623 Million USD | 12.45% |
| 2013 Q2 | 734 Million USD | 7.47% |
| 2012 Q3 | 540 Million USD | 0.0% |
| 2012 Q4 | 721 Million USD | 33.52% |
| 2012 FY | 2.34 Billion USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 3066.465% |
| Accuray Incorporated | 504 Thousand USD | -775495.238% |
| Align Technology, Inc. | 643.33 Million USD | -507.612% |
| Elevance Health Inc. | 133.96 Billion USD | 97.082% |
| AxoGen, Inc. | -21.46 Million USD | 18313.587% |
| Boston Scientific Corporation | 2.34 Billion USD | -66.837% |
| CVS Health Corporation | 13.74 Billion USD | 71.556% |
| Cardinal Health, Inc. | 1.24 Billion USD | -214.481% |
| Centene Corporation | 2.93 Billion USD | -33.413% |
| DaVita Inc. | 1.6 Billion USD | -143.888% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 59.395% |
| Hologic, Inc. | 970.2 Million USD | -302.907% |
| Humana Inc. | 4.01 Billion USD | 2.592% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -256.294% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -438.727% |
| Masimo Corporation | 136.5 Million USD | -2763.736% |
| Patterson Companies, Inc. | 252.92 Million USD | -1445.524% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -209.746% |
| ResMed Inc. | 1.31 Billion USD | -196.16% |
| Henry Schein, Inc. | 615 Million USD | -535.61% |
| Teladoc Health, Inc. | -248.55 Million USD | 1672.703% |
| Universal Health Services, Inc. | 1.17 Billion USD | -232.573% |
| Veeva Systems Inc. | 429.33 Million USD | -810.48% |
| Baxter International Inc. | 390 Million USD | -902.308% |
| Becton, Dickinson and Company | 2.11 Billion USD | -85.173% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -121.247% |
| Danaher Corporation | 5.38 Billion USD | 27.356% |
| Stryker Corporation | 3.88 Billion USD | -0.54% |
| Medtronic plc | 5.14 Billion USD | 24.009% |